Sharing-our-perspective-page-header2



Sharing perspectives leads to greater understanding and fuels innovation. The ​Optum Insights ​blog is where we share our perspective and challenge preconceptions to clear a new path forward


  • Indiana publishes workers’ comp drug formulary guidance

    by
    • Optum for Workers' Compensation
    | Dec 10, 2018
    Tag Icon
    Workers' Compensation, Government Affairs, Formularies
    The Indiana Workers’ Compensation Board (WCB) recently posted “guidance for implementation” of the drug formulary scheduled to take effect January 1, 2019


  • Over $100 billion in Medicare savings attributable to Medicare Secondary Payer Act

    by
    • Rafael Gonzalez
    | Dec 06, 2018
    Tag Icon
    Medicare Secondary Payer, Medicare Set-Aside, medicareinsights blog, Workers' Compensation, Settlement Solutions, Settlement
    The Medicare Secondary Payer Act turns 38 years old in December 2018. While it’s credited with saving more than $100 billion in taxpayers’ money since 1999, it’s not without its critics. Find out the impact of workers’ compensation, the pros and cons of MSP and what’s ahead. Read more on our blog.


  • Pharmacy Resource Guide 2018

    by
    • Optum Workers' Comp
    | Dec 05, 2018
    Tag Icon
    Opioids, Workers' Compensation, Pharmacy, Morphine Equivalent Dose, Medication Safety, Medication Plans, Medication Analysis
    Our latest Pharmacy Resource Guide identifies our Top 10 therapeutic classes; our Top 25 medications as a percentage of total spend, number of prescriptions and generic spend; plus latest trends from NCCI and a Brand-Generic Index of commonly-used workers’ compensation medications.


  • Lyrica® generic delayed until summer 2019 and Pfizer to increase drug prices

    by
    • Optum
    | Nov 29, 2018
    Tag Icon
    Workers' Compensation, Pharmacy, Clinical
    The U.S. Food and Drug Administration extended the period of market exclusivity for Lyrica® for six months, delaying the Lyrica generic. And Pfizer plans to increase prices. Read more on our blog.




Do you have a question for our
Government Affairs team?






Subscribe

Stay informed by signing up to receive our latest update. *Denotes a required field